Chandrima Mercantiles Limited

Consumer Defensive — Food Distribution · BSE

₹8.94−₹0.47 (−4.99%)

DalalBaazaar Score

56 / 100

🟡 Moderate

Verdict

CAUTION

Risk

High

Driven by high debt relative to equity, negative free cash flow, micro-cap size, which brings thin liquidity.

In simple words: The business is earning a fairly low return on the money invested in it, but sales are shrinking. Debt is the main factor to watch.

Decision support, not a buy or sell call.

As of 18 Oct 2026, 6:08 pm

Caution warranted. Multiple fundamental metrics — flagged in red below — point to either valuation stretch, leverage risk, or weakening profitability. This doesn't mean avoid the stock outright, but it does mean the burden of proof is on the growth story to justify the current price.

Understanding the Business

Company site ↗

The 60-second version of Chandrima Mercantiles Limited — what it does, how it earns, and who it competes with, before any of the numbers below.

What does this company do?

Chandrima Mercantiles Limited trades agriculture products. The company was founded in 1970 and is based in Ahmedabad, India.

IndustryFood Distribution

SectorConsumer Defensive

Annual revenue₹78 Cr

How does it make money?

Turns over ₹78 Cr a year. Of every ₹100 of sales, about ₹5 reaches shareholders as profit, with ₹6 left at the operating level before interest, tax and depreciation.

EBITDA margin6.5%

Net margin5.2%

Who are its competitors?

The closest listed comparisons in its industry are HINDUSTAN UNILEVER LTD., ITC LTD, NESTLE INDIA LIMITED, BRITANNIA INDUSTRIES LTD. These are the companies its valuation and returns are measured against elsewhere in this report.

HINDUSTAN UNILEVER LTD.P/E 42.5x · ROE 21.5%

ITC LTDP/E 16.6x · ROE 27.4%

NESTLE INDIA LIMITEDP/E 59.8x · ROE 79.9%

BRITANNIA INDUSTRIES LTDP/E 44.1x · ROE 51.0%

What is its competitive advantage?Little sign of one

Returns on capital of 4.3% are at or below what the capital likely costs. That is the financial pattern of a business competing largely on price, where advantage has to come from execution rather than position.

ROCE4.3%

ROE4.0%

Peer median ROE51.0%

What has been driving growth?

Profit has moved mainly because margins changed, not because the business sold much more. Over 3 years revenue moved +254% while net margin moved +6354% relative to itself. What this cannot tell you is which products, customers or geographies did the work — that lives in the segment disclosures of the annual report.

Revenue effect+254%

Margin effect+6354%

DalalBaazaar Score

56/ 100

Moderate

Weighted across six categories. Every point is explained below.

✓ Beta of 0.75 — historically steadier than the index
✗ Micro Cap: thinner liquidity and sharper drawdowns are normal
✗ High leverage magnifies any downturn in earnings
✗ Profits have swung sharply from year to year — earnings are hard to forecast
✗ Negative free cash flow means dependence on external funding

Quality vs. Valuation

Company Quality

54/ 100

Average

How good the business is, ignoring the share price entirely.

Valuation

75/ 100

Cheap

What you are being asked to pay, ignoring how good the business is.

A reasonable business at a reasonable price — neither the quality nor the valuation stands out in either direction.

Historical Valuation

Current P/E

7.4x

3Y Median

74.5x

40 monthly readings · mean 99.8x · range 15.6x–366.6x

Sector Median

43.3x

median of 4 sector peers

🟢Current valuation is approximately 90% below its 3y median of 74.5x. Cheaper than its own history, which is worth a reason too: the market may be pricing in something the backward-looking numbers do not show.

🟢Against its sector it trades 83% below the peer median of 43.3x.

vs. its own history

Cheap

74.5x median over 40 months · -90%

vs. sector peers

Cheap

43.3x median of 4 peers · -83%

vs. generic bands

Cheap

Below 15x

P/E (Trailing)

7.4x

P/B

2.78x

EV/EBITDA

60.7x

PEG

0.01

Dividend Yield

None

What's Good / What's Bad

🟢 What's Going Well4

Margins are improving
EBITDA margin is up from 0.1% to 6.5% over 3 years.
Return on capital is rising
ROCE has improved from 0.6% to 4.3%.
Valuation below its historical average
At 7.4x the stock trades 90% below its own median of 74.5x.
Consistently profitable
Profitable in every one of the last 4 reported years.

🔴 What Needs Attention3

Debt is rising
Total debt is up 42% over 3 years — worth checking what it funded.
Free cash flow is negative
The business is not currently covering its capital spending from operations.
Inventory building faster than sales
Inventory is up 8566% against revenue growth of 254% — stock may not be moving.

Red Flags

6 items require attention · 3 high · 3 watch

🔴High leverageFinancial
Debt/Equity of 5.70x — earnings must service borrowings before shareholders see anything.
🔴Profit up while operating cash flow fallsFinancial
Reported profit rose but cash generated by operations declined — worth checking whether earnings are being supported by non-cash items or working capital.
🔴Inventory building faster than salesFinancial
Inventory up 8566% against revenue up 254% — stock may not be moving.
🟡Debt is increasingFinancial
Total debt is up 42% over 3 years.
🟡Free cash flow is negativeFinancial
Free cash flow was -₹58 Cr in the latest year.
🟡Shareholders have been dilutedOwnership
Shares outstanding are up 1407% over 3 years — each existing share owns a smaller slice of the company.

Investment Thesis

🟢 Bull CaseWhat could make this work?

Margin expansion has further to run
EBITDA margin has risen from 0.1% to 6.5%. If that holds, profit compounds faster than sales and today's multiple looks cheaper in hindsight than it does now.
Priced below its own history
The stock trades 90% below its own median multiple. If the business performs as it has and simply re-rates back to normal, that gap is return on its own.
Cheaper than its peers
It trades 83% below the sector median. Either the market sees a problem the numbers do not show, or the discount closes.
Earnings have proved durable
Profitable in every one of the last 4 reported years. Consistency lowers the risk that any single bad year is structural rather than cyclical.

🔴 Bear CaseWhat could go wrong?

Leverage amplifies any setback
Debt/Equity of 5.70x. Interest is payable whether or not the business has a good year.
Earnings are hard to forecast
Profit has swung sharply from year to year, so any single year — good or bad — is a weak guide to the next. Cyclical earnings deserve lower multiples for that reason.
Size brings its own risk
Micro Cap businesses are thinly traded, so exits are harder in a falling market and single events move the price more than they would for a larger company.
Several serious flags at once
3 high-severity checks triggered. Individually each has an explanation; together they raise the chance that something structural is wrong rather than a one-off.

🟡 Key Things to WatchMeasurable tripwires, set against where this company stands today

1Revenue growth stays above 39% a year✓ 52.5% CAGR
Latest reported year was -83.8%. The bar is set below the established compounding rate, so ordinary variation does not trip it.
2EBITDA margin holds above 4%✓ 6.5%
Two points below today's level — enough room for noise, tight enough to catch real compression.
3Free cash flow remains positive✗ -₹58 Cr
Profit that never becomes cash eventually stops being profit.
4Debt / EBITDA stays below 2x✓ 1.2x
The ratio lenders write covenants against; it survives a small or negative equity base, unlike Debt/Equity.
5ROCE stays above 8%✗ 4.3%
Falling returns on capital are usually competition arriving, and show up here before they reach the margin.

Investment Checklist

5 / 11 checks passed

✗ Strong return on equity (ROE ≥ 15%)
✗ Strong return on capital employed (ROCE ≥ 15%)
✗ Healthy net margin (≥ 10%)
✗ Generates positive free cash flow
✗ Manageable leverage (Debt/Equity < 1.0)
✓ Adequate short-term liquidity (Current Ratio ≥ 1.0)
✗ Revenue growing year-over-year
✓ Profit growing year-over-year
✓ Not trading at an extreme valuation (P/E < 40x)
✓ Not buying right at the 52-week high
✓ Short-term technical trend isn't bearish

Price history

Quick Metrics

3 good · 3 neutral · 5 weak

Market Cap

₹298 Cr

Micro Cap

Smaller company — thin liquidity and deep drawdowns are normal here

P/E (Trailing)

7.4x

Cheap

Cheap against the generic band

P/B Ratio

2.78x

Fair

Moderate premium to the company's book value

EPS (TTM)

₹1.2

Profitable

Profitable on a per-share basis

ROE

4.0%

Weak

Weak capital efficiency

ROCE

4.3%

Weak

Low return on total capital employed

Debt/Equity

5.70x

High

High leverage

Revenue Growth (YoY)

-83.8%

Shrinking

Sales are contracting

Profit Growth (YoY)

448.8%

Healthy

Profits growing at a healthy clip

Dividend Yield

None

No dividend yield reported — usually means no payout, but verify if one was recently initiated

Free Cash Flow

-₹58 Cr

Cash burning

Spending more cash than the operations bring in

More Metrics

CMP

₹8.94

Operating Margin

9.2%

Average

Average margins

Net Margin

7.6%

Average

Average bottom-line conversion

Current Ratio

40.97

Comfortable

Healthy short-term liquidity

Beta (vs Nifty)

0.75

Defensive

Steadier than the market

52W Range Position

34%

Mid-range

Technical Snapshot

SMA 20 / SMA 50

11.5 / 11.4

Bullish alignment (short > long)

Price vs SMA 200

Above

Long-term uptrend

RSI (14)

11.4

Oversold zone

Financial Trend (4-Year)

Metric	FY23	FY24	FY25	FY26	3Y CAGR
Revenue	₹22 Cr	₹19 Cr	₹29 Cr	₹78 Cr	+52.5%
EBITDA	₹0 Cr	₹2 Cr	₹1 Cr	₹5 Cr	+555.0%
EBITDA Margin	0.1%	8.8%	2.4%	6.5%	—
PAT (Net Profit)	₹0 Cr	₹0 Cr	₹1 Cr	₹4 Cr	+511.6%
EPS	₹0.01	₹0.12	₹0.04	₹0.12	+146.6%
ROE	—	0.6%	0.7%	4.0%	—
ROCE	0.6%	0.5%	0.6%	4.3%	—
Total Debt	₹4 Cr	₹3 Cr	₹3 Cr	₹6 Cr	+12.3%
Free Cash Flow	-₹4 Cr	₹4 Cr	-₹38 Cr	-₹58 Cr	—

🟢 Revenue has grown at 52.5% a year over 3 years.

🟢 EBITDA has grown at 555.0% a year over 3 years.

🟢 EBITDA Margin has risen from 0.1% to 6.5% over 3 years (+6.4 pts).

🟢 PAT (Net Profit) has grown at 511.6% a year over 3 years.

🟢 EPS has grown at 146.6% a year over 3 years.

🟢 ROE has risen from 0.6% to 4.0% over 3 years (+3.4 pts).

🟢 ROCE has risen from 0.6% to 4.3% over 3 years (+3.6 pts).

🔴 Total Debt has grown at 12.3% a year over 3 years.

Balance Sheet & Cash Flow — FY2026

Total Assets

₹119 Cr

Total Liabilities

₹18 Cr

Total Debt

₹6 Cr

Cash & Equivalents

₹0 Cr

Operating Cash Flow

-₹58 Cr

Capex

—

Shareholding (proxy)

Institutional Holding

0.0%

Insider Holding

92.1%

Peer Comparison

Company	P/E	ROE
HINDUSTAN UNILEVER LTD.	42.5x	21.5%
ITC LTD	16.6x	27.4%
NESTLE INDIA LIMITED	59.8x	79.9%
BRITANNIA INDUSTRIES LTD	44.1x	51.0%

Recent News

1 mixed5 general

Chandrima Mercantiles Lower Circuit Streak: Day 2 Price and Data

Univest, 14 Oct

Chandrima Mercantiles sets Sept 10 as record date for 44th AGM

scanx.trade, 26 Aug

Chandrima Mercantiles - 10 penny stocks zoom up to 119% in just 2 months, 4 turn multibaggers. Did you own any?

The Economic Times, 30 Aug

Chandrima Mercantiles Upper Circuit Today: Price, Data and Peers

Univest, 12 Oct

BSE-Listed Chandrima Mercantiles Ltd (540829) Reinvents Itself With AI-Powered Agriculture Vision

Business Standard, 18 Nov

Chandrima Mercantiles Q1 Results: Net profit turns positive at ₹4.94 lakh

scanx.trade, 12 AugResults

🟡Mixed / dependsA results event. The figures on this page update once the new statements reach the data feed, which usually lags the announcement.

Watch Items

Revenue growth is negative (-83.8%) on the latest reported period — check if this is one-off or a trend.
Cross-check against the company's latest quarterly filing / investor presentation before acting.
RSI is in oversold territory — could mean either a bargain or a stock still falling for good reason. Check the 'why' before assuming reversal.

DalalBaazaar Thesis

🔴Business QualityWeak8.7/20

🟡Financial HealthAdequate10.6/20

🟢GrowthStrong14.9/20

🔴ProfitabilityWeak6.2/15

🟢ValuationAttractive11.8/15

🔴RiskHigh3.7/10

Unremarkable in both directions

A reasonable business at a reasonable price. Nothing here is alarming and nothing is compelling, which usually means the decision rests on things this data cannot see — the industry's direction, management's intent, and what else is available to you. 3 high-severity red flags sit above this conclusion and should be read first.

This thesis breaks if

✓Revenue growth stays above 39% a year52.5% CAGR
✓EBITDA margin holds above 4%6.5%
✗Free cash flow remains positive-₹58 Cr
✓Debt / EBITDA stays below 2x1.2x
✗ROCE stays above 8%4.3%